JunD protects against chronic kidney disease by regulating paracrine mitogens.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Investigation

• Publication date

  2003-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI17647PMID 12975469PMCID PMC193664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Animal Model Quantitative Trait Loci Influence Renal Disease Progression in a Mouse Model of Alport Syndrome

  2002cited by this paper
• AP-1 in mouse development and tumorigenesis

  2001cited by this paper
• Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

  2001cited by this paper
• Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

  2000cited by this paper
• Chronic activation of glomerular mitogen-activated protein kinases in Dahl salt-sensitive rats.

  2000cited by this paper
• Overexpression of Epidermal Growth Factor Induced Hypospermatogenesis in Transgenic Mice*

  2000cited by this paper
• Sodium Restriction Decreases AP-1 Activation after Nephron Reduction in the Rat: Role in the Progression of Renal Lesions

  2000cited by this paper
• Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.

  2000cited by this paper
• Targeted disruption of the murine junD gene results in multiple defects in male reproductive function.

  2000cited by this paper
• Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.

  2000cited by this paper
• Event-Related Potential and EEG Measures in Parkinson’s Disease without and with Dementia

  2000cited by this paper
• JunD protects cells from p53-dependent senescence and apoptosis.

  2000cited by this paper
• The lack of a functional p21WAF1/CIP1 gene ameliorates progression to chronic renal failure

  1999cited by this paper
• Genetic analysis of modifying loci on mouse chromosome 1 that affect disease severity in a model of recessive PKD.

  1999cited by this paper
• Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice.

  1999cited by this paper
• The course of the remnant kidney model in mice.

  1999cited by this paper
• Genetic susceptibility to end-stage renal disease.

  1999cited by this paper
• The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure.

  1999cited by this paper
• Early molecular mechanisms in the progression of renal failure: role of growth factors and protooncogenes.

  1998cited by this paper
• Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.

  1998cited by this paper
• Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts

  1997cited by this paper
• Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action.

  1997cited by this paper
• Protooncogene expression and diabetic kidney injury.

  1997cited by this paper
• Cyclin and cyclin-dependent kinase expression in the remnant glomerulus.

  1997cited by this paper
• Therapeutic intervention in glomerulonephritis by oligonucleotides.

  1997cited by this paper
• Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats.

  1996cited by this paper
• Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.

  1995cited by this paper
• Direct solution hybridization of guanidine thiocyanate-solubilized cells for quantitation of mRNAs in hepatocytes.

  1995cited by this paper
• Progression of renal disease and renal hypertrophy.

  1995cited by this paper
• Transforming growth factor alpha: expression, regulation, and biological activities.

  1995cited by this paper
• Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression.

  1995cited by this paper
• DNA synthesis is dissociated from the immediate-early gene response in the post-ischemic kidney.

  1995cited by this paper
• EGF and TGF-alpha in the human kidney: identification of octopal cells in the collecting duct.

  1994cited by this paper
• EGF and TGF-α in the human kidney: Identification of octopal cells in the collecting duct

  1994cited by this paper
• Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

  1994cited by this paper
• Inducible regulatory elements in the human cyclin D1 promoter.

  1994cited by this paper
• Renal cysts in transgenic mice expressing transforming growth factor-alpha.

  1994cited by this paper
• An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice

  1993cited by this paper
• Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model.

  1992cited by this paper
• Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor

  1992influential reference
• Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• Immunohistochemical identification of tubular segments in percutaneous renal biopsies

  1991cited by this paper
• Segmental distribution of epidermal growth factor binding sites in rabbit nephron.

  1990cited by this paper
• Changes in gene expression after temporary renal ischemia.

  1990cited by this paper
• Characterization of junD: a new member of the jun proto‐oncogene family.

  1989cited by this paper
• Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates.

  1987cited by this paper
• Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

  1984cited by this paper
• Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. A light microscope study

  1977cited by this paper

• Differential early tubular injury in minimal Change disease and Focal segmental Glomerulosclerosis: A Multifaceted analysis.

  2026cites this paper
• Single-cell transcriptomics combined with spatial transcriptomics reveals a fibrotic microenvironment in hyperuricemic nephropathy.

  2025cites this paper
• Scutellarin prevents obesity-induced renal fibrosis via reduced activation of AP-1

  2025cites this paper
• [Towards understanding chronic kidney disease].

  2023cites this paper
• Tissue factor binds to and inhibits interferon-α receptor 1 signaling.

  2023cites this paper
• Exploration of the shared genetic biomarkers in Alzheimer’s disease and chronic kidney disease using integrated bioinformatics analysis

  2023cites this paper
• Combining robust urine biomarkers to assess chronic kidney disease progression

  2023cites this paper
• Computational Analysis Reveals Distinctive Interaction of miRNAs with Target Genes in the Pathogenesis of Chronic Kidney Disease

  2023cites this paper
• Expression analysis of hsa_circ_0020397, hsa_circ_0005986, hsa_circ_0003028, and hsa_circ_0006990 in renal cell carcinoma.

  2022cites this paper
• Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy

  2022cites this paper
• PREDICTIVE MARKERS IN CHRONIC KIDNEY DISEASE.

  2022cites this paper
• The Metabolic Mechanism Underlying the Enhancing Effects of Glycine and Tryptophan on Kidney Function: How to Reduce EGFR Inhibitory Effect on AAs

  2021cites this paper
• Reversal of the renal hyperglycemic memory by targeting sustained tubular p21 expression

  2021influential citation
• MiRNAs as potential biomarker of kidney diseases: A review

  2020cites this paper
• Signaling pathways predisposing to chronic kidney disease progression.

  2020cites this paper
• Advances in the Detection, Mechanism and Therapy of Chronic Kidney Disease.

  2019cites this paper
• [Circulating microRNAs as potential biomarkers of chronic kidney disease].

  2019cites this paper
• Proximal Tubule Translational Profiling during Kidney Fibrosis Reveals Proinflammatory and Long Noncoding RNA Expression Patterns with Sexual Dimorphism.

  2019cites this paper
• Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy

  2018cites this paper
• The JNK Signaling Pathway in Renal Fibrosis

  2017cites this paper
• Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.

  2017cites this paper
• Spindle pole cohesion requires glycosylation-mediated localization of NuMA

  2017cites this paper
• Role of TGF-alpha in the progression of diabetic kidney disease.

  2017cites this paper
• Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome

  2017influential citation
• Transcriptional regulation of importin- (cid:2) 1 by JunD modulates subcellular localization of RNA-binding protein HuR in intestinal epithelial cells

  2016cites this paper
• Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.

  2016cites this paper
• Stat3 Controls Tubulointerstitial Communication during CKD.

  2016cites this paper
• Molecular pathways of chronic kidney disease progression.

  2016cites this paper
• β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells

  2016cites this paper
• Transcriptional regulation of importin-α1 by JunD modulates subcellular localization of RNA-binding protein HuR in intestinal epithelial cells.

  2016cites this paper
• CALL FOR PAPERS Cell Signaling: Proteins, Pathways and Mechanisms JunD enhances miR-29b levels transcriptionally and posttranscriptionally to inhibit proliferation of intestinal epithelial cells

  2015cites this paper
• Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease

  2015cites this paper
• JunD enhances miR-29b levels transcriptionally and posttranscriptionally to inhibit proliferation of intestinal epithelial cells.

  2015cites this paper
• Signal transduction in podocytes—spotlight on receptor tyrosine kinases

  2014cites this paper
• Cystic Gene Dosage Influences Kidney Lesions After Nephron Reduction

  2014cites this paper
• Hypertensive Renal Injury Is Associated With Gene Variation Affecting Immune Signaling

  2014cites this paper
• Role of kidney biomarkers of chronic kidney disease: An update.

  2014cites this paper
• Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats

  2013cites this paper
• Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model

  2013cites this paper
• Transcriptional regulation of the mouse CD11c promoter by AP-1 complex with JunD and Fra2 in dendritic cells.

  2013cites this paper
• A look at transactivation of the EGF receptor by angiotensin II.

  2012cites this paper
• Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease

  2012cites this paper
• A Look at Transactivation of the EGF Receptor by Angiotensin II

  2012cites this paper
• A transcriptional network underlies susceptibility to kidney disease progression

  2012cites this paper
• Identification of a major chronic renal failure susceptibility locus in mice: perhaps EGFR determines what happens to eGFR.

  2011cites this paper
• TGF- Mediates Genetic Susceptibility to Chronic Kidney Disease

  2011cites this paper
• Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease

  2011cites this paper
• EGFR signaling in podocytes at the root of glomerular disease

  2011cites this paper
• TGF-alpha mediates genetic susceptibility to chronic kidney disease.

  2011cites this paper
• The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis

  2011cites this paper
• A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.

  2010cites this paper
• Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

  2010cites this paper
• The Multi-Gene Family of Transcription Factor AP-1

  2010cites this paper
• Polyamines Regulate the Stability of JunD mRNA by Modulating the Competitive Binding of Its 3′ Untranslated Region to HuR and AUF1

  2010cites this paper
• Jun and JunD-dependent functions in cell proliferation and stress response

  2010cites this paper
• Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

  2010cites this paper
• Antihypertrophic effect of hemin in deoxycorticosterone acetate-salt-induced hypertensive rat model

  2009cites this paper
• Mitogen activated protein kinases in renal fibrosis.

  2009cites this paper
• The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

  2009cites this paper
• Crescentic nephritis--is it in your genes?

  2008cites this paper
• JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function.

  2008cites this paper
• Translational Nephrology Crescentic nephritis—is it in your genes? ∗

  2008cites this paper
• A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.

  2007cites this paper
• Induced JunD in intestinal epithelial cells represses CDK4 transcription through its proximal promoter region following polyamine depletion.

  2007cites this paper
• Dialogue entre l’angiotensine et le récepteur du facteur de croissance épidermique dans les maladies rénales chroniques : vers une nouvelle approche thérapeutique

  2006cites this paper
• JunD is a profibrogenic transcription factor regulated by Jun N‐terminal kinase‐independent phosphorylation

  2006cites this paper
• [Angiotensin and EGF receptor cross-talk in chronic kidney diseases: towards a new therapeutic approach].

  2006cites this paper
• Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach

  2005cites this paper
• The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2).

  2005cites this paper
• Menin Suppresses Osteoblast Differentiation by Antagonizing the AP-1 Factor, JunD*

  2005cites this paper
• Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis.

  2005cites this paper
• JunD regulates lymphocyte proliferation and T helper cell cytokine expression

  2004cites this paper
• Renal phenotype is exacerbated in Os and lpr double mutant mice.

  2004cites this paper